WormBase Tree Display for Gene: WBGene00015400
expand all nodes | collapse all nodes | view schema
WBGene00015400 | SMap | S_parent | Sequence | C03G6 | |||||
---|---|---|---|---|---|---|---|---|---|
Identity | Version | 2 | |||||||
Name | CGC_name | cyp-35A2 | |||||||
Sequence_name | C03G6.15 | ||||||||
Molecular_name | C03G6.15 | ||||||||
C03G6.15.1 | |||||||||
CE35217 | |||||||||
Other_name | CELE_C03G6.15 | Accession_evidence | NDB | BX284605 | |||||
Public_name | cyp-35A2 | ||||||||
DB_info | Database | AceView | gene | 5H840 | |||||
WormQTL | gene | WBGene00015400 | |||||||
WormFlux | gene | WBGene00015400 | |||||||
NDB | locus_tag | CELE_C03G6.15 | |||||||
Panther | gene | CAEEL|WormBase=WBGene00015400|UniProtKB=O02628 | |||||||
family | PTHR24300 | ||||||||
NCBI | gene | 182177 | |||||||
RefSeq | protein | NM_072479.7 | |||||||
TrEMBL | UniProtAcc | O02628 | |||||||
UniProt_GCRP | UniProtAcc | O02628 | |||||||
OMIM | gene | 601130 | |||||||
Species | Caenorhabditis elegans | ||||||||
History | Version_change | 1 | 28 May 2004 13:30:56 | WBPerson1971 | Event | Imported | Initial conversion from CDS class of stlace from WS125 | ||
2 | 21 Sep 2004 09:38:16 | WBPerson1971 | Name_change | CGC_name | cyp-35A2 | ||||
Status | Live | ||||||||
Gene_info | Biotype | SO:0001217 | |||||||
Gene_class | cyp | ||||||||
Allele (33) | |||||||||
Strain | WBStrain00036000 | ||||||||
WBStrain00036030 | |||||||||
RNASeq_FPKM (74) | |||||||||
GO_annotation (15) | |||||||||
Ortholog (177) | |||||||||
Paralog (44) | |||||||||
Structured_description | Concise_description | cyp-35A2 encodes one of over 80 C. elegans cytochrome P450s, NADPH-dependent monooxygenases that metabolize endogenous and exogenous compounds; RT-PCR experiments indicate that cyp-35A2 mRNA is upregulated in response to treatment with xenobiotics, such as PCBs (polychlorinated biphenyls) or PAHs (polycyclic aromatic hydrocarbons); loss of cyp-35A/C gene family activity in the presence of xenobiotics can diminish the reproductive decline seen in wild-type worms treated with the same compounds; in addition, cyp-35A(RNAi) also results in a reduction of fat content; cyp-35A2 reporter gene fusions are strongly expressed in the intestine following treatment with xenobiotics. | Paper_evidence | WBPaper00004966 | |||||
WBPaper00005655 | |||||||||
WBPaper00025207 | |||||||||
WBPaper00031939 | |||||||||
Curator_confirmed | WBPerson1843 | ||||||||
Date_last_updated | 26 Feb 2009 00:00:00 | ||||||||
Automated_description | Predicted to enable heme binding activity; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; and steroid hydroxylase activity. Involved in response to xenobiotic stimulus. Predicted to be located in cytoplasm and intracellular membrane-bounded organelle. Expressed in intestine. Human ortholog(s) of this gene implicated in several diseases, including gastrointestinal system cancer (multiple); glucose metabolism disease (multiple); and lung disease (multiple). Is an ortholog of several human genes including CYP2A13 (cytochrome P450 family 2 subfamily A member 13); CYP2A6 (cytochrome P450 family 2 subfamily A member 6); and CYP2A7 (cytochrome P450 family 2 subfamily A member 7). | Paper_evidence | WBPaper00065943 | ||||||
Curator_confirmed | WBPerson324 | ||||||||
WBPerson37462 | |||||||||
Inferred_automatically | This description was generated automatically by a script based on data from the WS291 version of WormBase | ||||||||
Date_last_updated | 29 Nov 2023 00:00:00 | ||||||||
Disease_info | Potential_model (57) | ||||||||
Molecular_info | Corresponding_CDS | C03G6.15 | |||||||
Corresponding_CDS_history | C03G6.15:wp106 | ||||||||
Corresponding_transcript | C03G6.15.1 | ||||||||
Other_sequence | ES740345.1 | ||||||||
Tcol_isotig20275 | |||||||||
Associated_feature | WBsf652771 | ||||||||
WBsf669117 | |||||||||
WBsf233940 | |||||||||
Experimental_info | RNAi_result | WBRNAi00039543 | Inferred_automatically | RNAi_primary | |||||
WBRNAi00116295 | Inferred_automatically | RNAi_primary | |||||||
WBRNAi00092682 | Inferred_automatically | RNAi_primary | |||||||
WBRNAi00010068 | Inferred_automatically | RNAi_primary | |||||||
WBRNAi00114818 | Inferred_automatically | RNAi_primary | |||||||
WBRNAi00078475 | Inferred_automatically | RNAi_primary | |||||||
WBRNAi00106221 | Inferred_automatically | RNAi_primary | |||||||
WBRNAi00028398 | Inferred_automatically | RNAi_primary | |||||||
Expr_pattern | Expr1683 | ||||||||
Expr8189 | |||||||||
Expr11595 | |||||||||
Expr1029051 | |||||||||
Expr1036590 | |||||||||
Expr1143647 | |||||||||
Expr2010735 | |||||||||
Expr2028972 | |||||||||
Drives_construct | WBCnstr00004995 | ||||||||
WBCnstr00010373 | |||||||||
WBCnstr00019076 | |||||||||
WBCnstr00028873 | |||||||||
Construct_product | WBCnstr00019076 | ||||||||
WBCnstr00028873 | |||||||||
Microarray_results (14) | |||||||||
Expression_cluster (292) | |||||||||
Interaction (49) | |||||||||
Map_info | Map | V | Position | 0.715015 | Error | 0.002421 | |||
Positive | Positive_clone | C03G6 | Inferred_automatically | From sequence, transcript, pseudogene data | |||||
Mapping_data | Multi_point | 5576 | |||||||
Pseudo_map_position | |||||||||
Reference (27) | |||||||||
Remark | Map position created from combination of previous interpolated map position (based on known location of sequence) and allele information. Therefore this is not a genetic map position based on recombination frequencies or genetic experiments. This was done on advice of the CGC. | CGC_data_submission | |||||||
Method | Gene |